Dysphonia after Bevacizumab Rechallenge: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|8|3|423-425

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.8, Iss.3, 2015-10, pp. : 423-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report

By  

THE LARYNGOSCOPE, Vol. 128, Iss. 3, 2018-03 ,pp. : 593-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case Report of a Patient with Hereditary Hemorrhagic Telangiectasia Treated Successively with Thalidomide and Bevacizumab

By  

Case Reports in Oncology, Vol. 3, Iss. 3, 2010-12 ,pp. : 463-470

Karger

Access to resources Recommend Favorite

Long‐term survival with bevacizumab in heavily pretreated and platinum‐resistant mucinous ovarian cancer: A case report

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 44, Iss. 2, 2018-02 ,pp. : 347-351

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-07 ,pp. : 605-612

Karger

Access to resources Recommend Favorite

Esophageal Metastasis from Rectal Cancer Successfully Treated with Fluorouracil-Based Chemotherapy with Bevacizumab: A Case Report and Review of the Literature

By  

Case Reports in Oncology, Vol. 10, Iss. 2, 2017-05 ,pp. : 407-415

Karger

Access to resources Recommend Favorite